Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection

Circulation Research

Volumn 79, Issue 6, 1996, Pages 1143-1152

  Speir, Edith ^a,b   Shibutani, Tomoko ^a   Yu, Zu Xi ^a   Ferrans, Victor ^a   Epstein, Stephen E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MSC1650 ^*  (United States)

Author keywords

antioxidant; atherosclerosis; cytomegalovirus; nuclear factor B; reactive oxygen intermediate

Indexed keywords

ANTIOXIDANT; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029806823     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.6.1143     Document Type: Article

References (46)

1. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394. Comments.
2. Meinick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
3. Bruggeman CA, van Dam-Mieras MC. The possible role of cytomegalovirus in atherogenesis. Prog Med Virol. 1991;38:1-26.
4. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991;10:2247-2258.
5. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1-62.
6. Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem. 1994;269:28539-28542.
7. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A. 1993;90:1107-1111.
8. Cherrington JM, Mocarski ES. Human cytomegaiovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol. 1989;63:1435-1440.
9. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocatski ES. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989;8:4251-4258.
10. Huang ES. Human cytomegalovirus, III: virus-induced DNA polymerase. J Virol. 1975;16:298-310.
11. Davis MG, Huang ES. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol Appl Biochem. 1988;10:6-12.
12. Ghazal P, Young J, Giulietti E, DeMattei C, Garcia J, Gaynor R, Stenberg RM, Nelson JA. A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol. 1991;65:6735-6742.
13. Finco TS, Baldwin AS Jr. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J Biol Chem. 1993;268:17676-17679.
14. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910-1917.
15. Ohba M, Shibanuma M, Kuroki T, Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol. 1994;126:1079-1088.
16. Zhu H, Bannenberg GL, Moldeus P, Shertzer HG. Oxidation pathways for the intracellular probe 2′,7′-dichlorofluorescein. Arch Toxicol. 1994;68:582-587.
17. Alcami J, Barzu T, Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J Gen Virol. 1991;72:2765-2770.
18. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1990;87:9943-9947.
19. Seed B, Sheen JY. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 1988;67:271-277.
20. Padmanabhan R, Corsico CD, Howard TH, Holter W, Fordis CM, Willingham M, Howard BH. Purification of transiently transfected cells by magnetic affinity cell sorting. Anal Biochem. 1988;170:341-348.
21. Balew HC, Forrester FT, Lyerk HC, Velleca WM, Bird BR, Roberts JD. Basic Laboratory Methods in Virology. Atlanta, Ga: US Department of Health, Education, and Welfare; Center for Disease Control, Virology Branch; 1975.
22. Speir E, Epstein SE. Inhibition of smooth muscle cell proliferation by antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Circulation. 1992;86:538-547.
23. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, Superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593-597.
24. Albrecht T, Boldogh I, Fons MP, Valyi-Nagy T. Activation of protooncogenes and cell activation signals in the initiation and progression of human cytomegalovirus infection. In: Becker Y, Darai G, Huang ES, eds. Frontiers of Virology 2. New York. NY: Springer-Verlag; 1993:384-411.
25. Hellsten-Westing Y. Immunhistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry. 1993;100:215-222.
26. Krishna CM, Liebman JE, Kaufman D, DeGraff W, Hahn SM, Mitchell JB, Russo A. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys. 1992;294:98-106.
27. Spector T. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical. Biochem Pharmacol. 1988;37:349-352.
28. Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol. 1995;69:5391-5400.
29. Bellas RE, Lee JS, Sonenshein GE. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest. 1995;96:2521-2527.
30. Stenberg RM, Fortney J, Barlow SW, Magrane BP, Nelson JA, Ghazal P. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol. 1990;64:1556-1565.
31. Akaike T, Ando M, Oda T, Doi T, Ijiri S, Araki S, Maeda H. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest. 1990;85:739-745.
32. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:G567-G574.
33. Speir E, Shibutani T, Yu ZX, Epstein SE. Aspirin, by inhibiting free radical generation induced by cytomegalovirus infection of human smooth muscle cells, inhibits cytomegalovirus gene expression and cytomegalovirus replication. Circulation. 1995;92(suppl I):I-229. Abstract.
34. Legrand-Poels S, Vaira D, Pincemail J, van de Vorst A, Piette J. Activation of human immunodeficiency virus type I by oxidative stress. AIDS Res Hum Retroviruses. 1990;6:1389-1397.
35. Wathen MW, Stinski MF. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol. 1982;41:462-477.
36. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transeriptional activator NFκB and its inhibitor, IκB-α. Proc Natl Acad Sci U S A. 1993;90:2532-2536.
37. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay R. Inducible nuclear expression of newly synthesized IκB-α negatively regulates DNA-binding and transcriptional activities of NFκB. Mol Cell Biol. 1995;15:2689-2696.
38. Segal AW. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest. 1989;83:1785-1793.
39. 2 from the oxidative burst orchestrates the plant hypersensitive disease resistance response. Cell. 1994;79:583-593.
40. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci. 1996;21:83-267, 1456-1462.
41. Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, Patterson C, Perella MA, Cooke C, Wang H, Haber E, Schlegel R, Lee ME. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667-3670.
42. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A. 1996;93:11848-11852.
43. Peterhans E. Sendai virus stimulates chemiluminescence in mouse spleen cells. Biochem Biophys Res Commun. 1979;91:383-392.
44. Grech ED, Dodd NJF, Jackson MJ, Morrison WL, Faragher EB, Ramsdale DR. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol. 1996;77:122-127.
45. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin invest. 1993;91:2546-2551.
46. Baenerle PA, Baltimore D. A 65-kD subunit of active NFκB is required for inhibition of NFκB by IκE. Genes Dev. 1989;3:1689-1698.